Autogenous Injections in Temporomandibular Disorders: A Systematic Review
Journal of Clinical Medicine · 20.09.2025 · 14 (18) · 6640
DOI: 10.3390/jcm14186640 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.09.2025. Verfasst von Sylwia Orzeszek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Dentistry, Wroclaw Medical University, 50-425 Wroclaw, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Background/Objectives: Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal conditions affecting the temporomandibular joints and masticatory muscles. In recent years, autogenous injections have been investigated as minimally invasive therapeutic options to alleviate pain and improve function. However, the clinical effectiveness of such therapies across different TMD phenotypes remains uncertain.
Methods
Electronic searches were performed in MEDLINE, Embase, and Web of Science for articles published between January 2015 and May 2025. Studies involving intra-articular or intra-muscular autogenous injections in TMD patients were included. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool and the Joanna Briggs Institute (JBI) Critical Appraisal Tools.
Results
Thirteen studies met the inclusion criteria. Six were randomized controlled trials (RCTs) and seven were non-randomized clinical studies. Ten studies evaluated intra-articular conditions such as disc displacement or Temporomandibular Joint (TMJ) osteoarthritis, while three focused on myofascial pain. Platelet-Rich Plasma (PRP) was the most frequently investigated agent. Most studies reported statistically significant reductions in pain and improvements in mandibular mobility following autogenous injections, with PRP generally outperforming comparators such as hyaluronic acid, corticosteroids, or saline. No serious adverse events were reported.
Conclusions
All PRP and Platelet-Rich Fibrin (PRF) injection protocols reviewed were effective in reducing pain and improving mobility in patients with TMD. However, differences in protocols and follow-up times prevented a meta-analysis from being conducted. More standardized RCTs are needed to determine clear clinical guidelines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Dentistry, Wroclaw Medical University, 50-425 Wroclaw, Poland.
- Clinic of Stomatology and Maxillofacial Surgery, Faculty of Medicine, University Pavol Josef Šafárik and Akademia Košice, Košice, 041 90 Kosice, Slovakia.
- Department of Rehabilitation of Musculoskeletal System, Pomeranian Medical University, 70-204 Szczecin, Poland.
- Private Dental Practice, 53-407 Wroclaw, Poland.
ORCID-Profile: Andrej Jenca, Piotr Seweryn
Förderung
- Wroclaw Medical University
Zitieren
APA
Orzeszek, S., Malysa, A., Jenca, A., Gebska, M., Sluzalec-Wieckiewicz, K., Zietek, M., & Seweryn, P. (2025). Autogenous Injections in Temporomandibular Disorders: A Systematic Review. Journal of Clinical Medicine, 14(18), 6640. https://doi.org/10.3390/jcm14186640
Vancouver
Orzeszek S, Malysa A, Jenca A, Gebska M, Sluzalec-Wieckiewicz K, Zietek M, et al. Autogenous Injections in Temporomandibular Disorders: A Systematic Review. Journal of Clinical Medicine. 2025;14(18):6640. doi:10.3390/jcm14186640
BibTeX
@article{Orzeszek2025,
author = {Orzeszek, Sylwia and Malysa, Andrzej and Jenca, Andrej and Gebska, Magdalena and Sluzalec-Wieckiewicz, Katarzyna and Zietek, Marek and Seweryn, Piotr},
title = {Autogenous Injections in Temporomandibular Disorders: A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {18},
pages = {6640},
doi = {10.3390/jcm14186640}
}
EUVIMED